Toggle Nav
Close
  • Menu
  • Setting

A-1331852

Catalog No.
B6164
BCL-XL inhibitor, potent and selective
Grouped product items
SizePriceStock Qty
5mg
$99.00
In stock
10mg
$165.00
In stock
25mg
$337.00
In stock
50mg
$528.00
In stock
100mg
$858.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Ki: 6 nM for BCL-2 TR-FRET

A-1331852 is a potent and selective inhibitor of BCL-XL.

Apoptosis is reported to be regulated by a family of closely related proteins exemplified by B cell lymphoma protein 2 (BCL-2), which is the first discovered family member. BCL-2 family proteins are divided by one to four BCL-2 homology motifs and can be further subdivided into pro- and antiapoptotic subsets.

In vitro: A-1331852 was identified as a potent BCL-XL inhibitor demonstrating cellular activity 10- to 50-fold more potent than its analog A-1155463 and the previouly reported BCL-XL inhibitor, navitoclax, respectively. Moreover, A-1331852 could selectively disrupt BCL-XL–BIM complexes and induce the apoptosis hallmarks in BCL-XL–dependent Molt-4 cells with median IC50 values in the low nanomolar range but did not affect MEF cells without BAK or BAX [1].

In vivo: Previous animal study found that A-1331852 could demonstrate antitumor efficacy in the Molt-4 xenograft model, such as tumor regressions as a single agent. In addition, in the NCI-H1963.FP5 xenograft model of SCLC, it was found that A-1331852 combined with venetoclax was able to recapitulate the efficacy of navitoclax [1].

Clinical trial: Up to now, A-1331852 is still in the preclinical development stage.

Reference:
[1] Leverson JD et al.  Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Sci Transl Med. 2015 Mar 18;7(279):279ra40. doi: 10.1126/scitranslmed.aaa4642.

Product Citation

Chemical Properties

StorageStore at -20°C
M.Wt658.81
Cas No.1430844-80-6
FormulaC38H38N6O3S
Solubility≥113.6 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
Chemical Name3-(1-(adamantan-1-ylmethyl)-5-methyl-1H-pyrazol-4-yl)-6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)picolinic acid
SDFDownload SDF
Canonical SMILESO=C(C1=NC(N2CC3=C(C=CC=C3C(NC4=NC5=CC=CC=C5S4)=O)CC2)=CC=C1C6=C(C)N(CC78CC9CC(C8)CC(C9)C7)N=C6)O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control

Chemical structure

A-1331852

Related Biological Data

A-1331852

Related Biological Data

A-1331852

Related Biological Data

A-1331852

Related Biological Data

A-1331852

Related Biological Data

A-1331852

Related Biological Data

A-1331852

Related Biological Data

A-1331852